JulioJHajdenbergMDFACP(He/Him)
Hematology • Boston, MAHematologic Oncology
Senior Medical Director Black Diamond Therapeutics, Cambridge MA
Dr. Hajdenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Jamaica Plain VA Medical Centerhematologyoncology
130 S Huntington Ave
Boston, MA 02130Phone+1 617-232-9500Fax+1 407-425-5203
Education & Training
Massachusetts Institute of TechnologyCertification, Drug and Medical Device Development, 2022
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1991 - 1994
University of Buenos AiresClass of 1990
Certifications & Licensure
NH State Medical License 1996 - Present
FL State Medical License 1997 - 2026
MA State Medical License 1994 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors Castle Connolly, 2016-2022
- Health Care Provider of the Year Leukemia Lymphoma Society, 2016
Publications & Presentations
PubMed
- Partial Response to Small Molecule Inhibition in a Case of Anaplastic Large Cell Lymphoma.Sarah Young, Amirah Kuzu, Mike Magill, Julio Hajdenberg
Cureus. 2022-03-01 - Severe bleeding after haemorrhoidal banding in a haemophilia patient treated with emicizumab.Jacob Barish, Julio Hajdenberg
Haemophilia. 2021-05-22 - 3 citationsHigh Thermal Amplitude Red Blood Cell Agglutinating Cold Type Autoantibodies in a Case of Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia and Multiorgan Fail...Hatem Hassanein, Julio Hajdenberg
Journal of Medical Cases. 2021-01-01
Press Mentions
Reader Responses: Can I Start Cytoreductive Therapy in a Patient with Low-Risk Polycythemia Vera?December 1st, 2020- Reader Responses: How Would You Treat This Patient with JAK2-Positive Essential Thrombocythemia?November 30th, 2020
- Reader Responses: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?November 1st, 2020
- Join now to see all
Committees
- Member, IDEA/ASCO 2020 - 2022
- Member, Prostate Cancer Advisory Committee/State of Florida 2016 - 2021
Professional Memberships
- Member
- Member
- FLASCO: Florida Society of Clinical OncologyMember
- Massachusetts Medical SocietyMember
Other Languages
- Spanish
Industry Relationships
- Senior Medical Director, Black Diamond Therapeutics2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
